Sara Mageit

The new project will build a global information knowledge platform to help the healthcare industry deliver more efficient care to COVID-19 patients.

Also, The Royal Marsden, in the UK, launches AI virtual agent to support key workers post lockdown.

The Oxford University spin-out is also calling on the government to review what data it is collecting on the COVID-19 crisis by ethnic groups.     

Medicspot has announced a partnership with Asda to offer in-store GP video-consultations in the latest expansion of digital primary care services.

Local authorities are to be given access to postcode-level data on people testing positive for coronavirus in their areas. 

Five of Sheffield’s labour MPs have written to the prime minister, Boris Johnson, and health secretary, Matt Hancock, to seek support for the building of the Child Health Technology (CCHT) on the Sheffield Olympic Legacy Park.   The centre already has the backing of large international companies including Philips, Cannon Medical, IBM Watson Health, Sheffield Children’s Hospital and South Yorkshire and Bassetlaw Integrated Care System. WHY IT MATTERS Once developed, the aim is to create a clinical research space that will be integral to bringing long-term and sustainable change to children’s health and wellbeing. The proposed 51,300-square-feet space will also enable a partnership with the current research programmes undertaken at Sheffield Children’s Hospital, such as Technology Innovation Transforming Child Health and Young People MedTech Cooperative. The new centre will deliver other wider health benefits and opportunities for the economy of the Sheffield City region, including the acceleration and adoption of health tech products and creating high value job opportunities.   THE LARGER CONTEXT The letter by the MPs comes as Johnson recently announced his "New Deal" plan of infrastructure investment to "build the UK back to health," in which he pledged £1.5 billion to go toward the building and maintenance of hospitals. ON THE RECORD The letter highlights that the CCHT would create an “environment where the NHS, academia and the private sector collaborate in innovations that can be commercialised and a critical mass of health and wellbeing research and innovation.” It also states that at a capital cost of £24 million, the new centre would “deliver excellent value for money and major benefits for the wider health of the economy of Sheffield City Region.”

Leader in AI-powered cancer diagnostics, Ibex Medical Analytics and provider of digital pathology services in the NHS, LDPath, have announced the UK’s first rollout of clinical grade AI application for cancer detection in pathology. This platform will support pathologists in enhancing diagnostic accuracy and efficiency. WHY IT MATTERS Over the years, a global increase in cancer cases has coincided with a decline in the number of pathologists around the world. Traditional pathology involves manual processes that have remained the same for years. These processes involve slides to be analysed by pathologists using microscopes, and reporting is often carried out on pieces of paper. The limited availability of pathologists has required couriers to transport glass slides containing tissue samples between different locations to access expert opinions.  LDPath, which provides histopathological imaging and reporting services to 24 NHS trusts throughout the UK, will use its position as a digitally enabled provider within the NHS to integrate Ibex’s Galen Prostate platform into its digital pathology workflow. With the CE-marked platform from Ibex, prostate biopsies at LDPath will be reviewed by an AI algorithm concomitant with the pathologist’s diagnosis. THE LARGER CONTEXT In recent times, it has been highlighted that the shortage of pathologists in the UK has led to delays in cancer diagnosis, which can take up to six weeks. Together with increased demand, this is exerting pressure on pathology departments while also raising concerns about diagnostic accuracy. In addition, such supply and demand issues contribute to critical issues for NHS diagnostics, including breached National Institute for Health and Care Excellence (NICE) cancer guidelines and an increased dependency on expensive temporary solutions. ON THE RECORD Sanj Lallie, director of operations at LDPath said: “This is a significant step in realising the benefits of AI tools within the UK as we continue to redefine traditional workflows across our NHS network. Our NHS clients will benefit from this additional quality assurance measure as well as new service offerings, including singular AI screening of all prostate biopsies within a 24 hour period and UKAS internal audits.” Joseph Mossel, Ibex Medical Analytics CEO and co-founder said: “We are excited to collaborate with LDPath to bring a paradigm shift for pathology in the UK, and around the world, increasing efficiency and improving accuracy of cancer diagnostics.” “Cancer cases continue to rise, and with the pathology practice experiencing a worldwide shortage, AI-based technologies can drive new workflows for pathology that will be critical for improving cancer care practices for patients, pathologists, labs and entire healthcare systems.” 

With a large backlog of appointments caused by coronavirus, some hospitals in England and Wales have started using algorithms to prioritise patients most urgently in need of care and to help clear the mounting numbers. Multiple companies are vying to get into this space from Babylon's AI services which provide health information, to DrDoctor, which recently released a new AI software adopted to collate and automatically rate patient’s responses with digital questionnaires. WHY IT MATTERS DrDoctor’s software assesses the urgency of a patient's illness with a traffic light scoring system, giving patients either a green, amber or a red score. Tom Whicher, CEO of DrDoctor estimates that if every hospital in the country adopted his technology, the time needed to get through the backlog would be dramatically reduced from four years to ten months. DrDoctor has also stressed that the tool will not decide anything for patients, it does not make clinical suggestions or rule out any patients form receiving care. The platform will present the data and the clinician ultimately makes the decision. AI like this can utilize machine-learning technology to identify unnecessary appointments. Not only will it reduce the backlog burden, but it can also help to significantly alleviate the need for in-person appointments, pushing towards more virtual interactions for less urgent medical needs. THE LARGER TREND Waiting lists have grown tremendously because of the pandemic, prompting senior health officials to warn the public that 10 million people could be waiting for treatment by Christmas. Several hospitals in England have already rolled out DrDoctor’s tool, including community hospital, Aneurin Bevan, which signed a four-year deal with the provider earlier this year and is using it across 20 specialisms.  However, a concern raised recently is the theme of digital health gap inequalities in which researchers have warned that such tools could worsen health inequalities due to certain groups having greater access to the internet and technology, as well as being more digitally literate. This could mean that certain groups might not be accounted for in the data. There is also trepidation surrounding a computer’s ability to effectively decide whether medical needs are deemed as urgent. Particularly as health providers such as Babylon Health have been critised for claiming its symptom checker could diagnose health issues. ON THE RECORD Whicher told Healthcare IT News: "Our mission at DrDoctor is to solve the challenge of rising demand and costs in healthcare and ensure every patient receives the care they need. We're delighted to be able to present real world examples of this working at scale. There is no doubt that healthcare is at an inflection point. It's medicine's industrial revolution. By working together we can use technology to rise to this challenge"

GE HEALTHCARE LAUNCHES NEW AI SUITE TO DETECT CHEST X-RAY ABNORMALITIES Leading global medical technology solutions innovator, GE Healthcare has launched the Thoracic Care Suite, which uses AI to scan for eight chest X-ray abnormalities, including pneumonia indicative of COVID-19, which is a key cause of mortality in patients who contract the virus. The launch of the AI suite is a part of GE Healthcare’s larger effort to help ensure clinicians on the frontlines have the equipment they need to quickly diagnose and effectively treat COVID-19 patients. It will also feature an algorithm to detect tuberculosis, which according to the World Health Organisation, affects approximately 10 million people every year. “The pandemic has proven that data, analytics, AI and connectivity will only become more central to delivering care. This new offering is the latest example of how X-ray and AI can uphold the highest standard of patient care amidst the most modern of disease threats,” says Kieran Murphy, president & CEO, GE Healthcare. VIDEO GAME PRESCRIPTION TREATMENT FOR CHILDREN WITH ADHD Akili announced that it has received approval from the Conformité Européenne (CE) to market EndeavorRx as a prescription-only digital therapeutic software intended for the treatment of attention deficit hyperactivity disorder (ADHD). Delivered through a video game experience, EndeavorRx has been studied across five clinical studies with more than 600 children diagnosed with ADHD. This included a prospective, randomised, controlled study published in The Lancet Digital Health journal, which showed EndeavorRx improved objective measures of attention in children with ADHD. While EndeavorRx is not yet available in Europe, the CE Mark enables Akili to market EndeavorRx in European Economic Area (EEA) member countries. The CE Mark follows last week’s US Food and Drug Administration (FDA) decision, which made EndeavorRx the first FDA-cleared prescription treatment delivered through a video game.  “Following our recent FDA clearance, the CE mark is another important milestone for Akili,” said Anil Jina, MD, chief medical officer of Akili. “This approval provides a path for the future expansion into Europe and will allow us to offer a new non-drug treatment option to families of children living with ADHD.” LONDON'S HEALTH HELP NOW APP TO CLOSE From the end of June, the Health Help Now app will no longer be available, following a decision by the NHS in North-West London to decommission the service. The app was introduced to provide residents in North-West London with digital support and to direct them to a range of health support and advice services. However, due to the app not being widely taken up across the eight boroughs and the lack of local NHS clinical resource, it no longer had the financial resource to be widely promoted and was consequently not able to generate key clinical content that residents once relied on. Taking into account these concerns, the local NHS engaged with stakeholders and undertook an equality and health inequalities analysis (EHIA) screening exercise to consider the viability of Health Help Now. Stakeholders expressed the views that the lack of clinical oversight made the app clinically unsafe. Furthermore, It is understood that there were calls for the app to be stopped around three years ago. Residents are now being encouraged to sign up for the NHS app, which offers NHS services such as repeat prescription ordering, appointment booking, symptom checkers, and advice about coronavirus. Kevin Jarrold, joint chief information officer of North-West London Health and Care Partnership said: “Following the decision to close Health Help Now we need to concentrate on encouraging people to download and use the national NHS App which offers an excellent alternative that is backed by NHS England and NHSX.” STUDY SHOWS DIGITAL MENTAL HEALTH THERAPY LONG-TERM BENEFITS A new study published by npj Digital Medicine has revealed that digital mental health interventions have a significant long-term impact on anxiety and depression recovery. The research was undertaken by digital therapeutics provider, SilverCloud Health, with the School of Psychology at Trinity College, the University of Dublin, and health economics analysis from the University of Sheffield. With more than 360 service users in England on the Improving Access to Psychological Therapies (IAPT) programme involved, the findings are the world’s largest-ever study of its kind. The study comes as mental health providers anticipate significant growth in disorders and anxieties linked to the pandemic and emerging as the lockdown continues to ease. The research highlights how digital cognitive behavioural therapy (iCBT) as part of wider psychological care can deliver strong clinical improvements and recovery. Psychiatric interviews of participants at three months after treatment found that, overall, 56.4% no longer had a diagnosis of anxiety and/or depression. A further decrease in symptom scores was seen after 12 months, on average a 50% decrease. Judith Chapman, development director at Berkshire Healthcare, said: “The trial has demonstrated that digital treatment has a strong place alongside conventional face-to-face mental health therapy, which is not a second class treatment offer but a robust evidence-based and accessible treatment for the population, especially during the unprecedented and challenging times we are experiencing due to COVID-19.” SOMERSET NHS FOUNDATION TRUST ADVANCES ITS OPEN IT STRATEGY  Somerset NHS Foundation trust has gone live with its e-prescribing and medications management solution from Better. The trust, which was formed on 1 April 2020 when the Somerset Partnership and Taunton and Somerset NHS foundation trusts merged, is using OPENeP across its surgical services. The move is an important milestone for the trust’s IT strategy, which is to integrate key systems using the Better openEHR platform and to add clinical functionality by using the Better Form Builder. It has also supported the trust’s COVID-19 response and laid the foundations for launch across the trust’s medicine directorate later this summer. Andrew Forrest, the trust’s CIO, explained: “We decided to pursue an open platform and portal-based approach to developing an electronic patient record. “This offered several advantages, such as allowing us to create a central record and clinical data repository that we can use to feed the best of suite clinical systems that we are adding according to our needs and resources.” CLINERION’S PATIENT NETWORK EXPLORER OFFERS CLINICAL TRIAL PERFORMANCE DATA Switzerland-based data technology company, Clinerion has launched Clinerion’s Patient Network Explorer, a new functionality for analysing clinical site performance. This platform will add new, actionable functionality to support clinical trial sponsors during site selection as a result of Clinerion’s collaboration with LongTaal, a clinical trial informatics company. Users of Clinerion’s Patient Network Explorer can review clinical trial statistics on an individual hospital level. Derived and mapped from multiple public sources, this new functionality allows for browsing, filtering, reviewing, and comparing site trial performance statistics. This will include breakdowns on studies by condition, trial phase and recruitment status. “It is crucial, during site selection, to have as much information at hand as possible, to avoid expensive detours and dead ends,” says Ian Rentsch, CEO of Clinerion. “Patient Network Explorer is becoming everything a sponsor needs to identify the right site for their trials.” NEW COVID-19 TRACKING TOOL APPEARS ON SMARTPHONES This week, a COVID-19 tracing software appeared in the settings of both Android and iPhones as part of a system update that will let future contact tracing apps measure the distance between two handsets. Not to be mistaken for a tracing app itself, the “exposure notification” is a tool jointly created by Google and Apple that will enable contact tracing apps to send a notification if you have been exposed to COVID-19. Apple and Google state that “Contact tracing apps will be developed by your local public health authority, not by Google or Apple.” “Public health authorities around the world are building apps that use the Exposure Notifications System to help their contact tracing efforts.” Once you opt-in to the notification system, the tool will generate a random ID for your device and enable an app to run in the background while still using Bluetooth. The tool is switched off by default.

Ascom UK, Person Centred Software, ATLAS eMAR and PainChek are partnering to help care home-owners and staff go digital.